Niclosamide as a potential antivirulence agent disrupting quorum sensing in Pseudomonas aeruginosa: A molecular and in silico approach
Related Experiment Video
Updated: May 15, 2025

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Malik Suliman Mohamed1, Raya Soltane2, Eid Alatwi3
1Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, 72388, Al-Jouf, Kingdom of Saudi Arabia.
Abstract:
Pseudomonas aeruginosa is a formidable pathogen linked to various challenging infections. Quorum sensing (QS) plays a pivotal role in regulating the virulence factors of P. aeruginosa. Targeting QS represents a promising strategy for mitigating P. aeruginosa virulence. This study explores the potential of niclosamide (NIC) as an antivirulence agent, emphasizing its effects on biofilm formation, pigment production, and its molecular interaction with the QS regulator, LasR. A comprehensive methodology was employed, encompassing in-silico, molecular, and in vitro analyses to assess the antivirulence properties of NIC. Sub-inhibitory concentrations of NIC (64 μg/ml) were evaluated for their capacity to inhibit biofilm formation and pigment production in P. aeruginosa. NIC resulted in a 45.4 % reduction in biofilm formation, a 48.8 % decrease in pyocyanin production, and a 41.3 % reduction in rhamnolipid production. Furthermore, NIC displayed a dose-dependent antagonistic effect on LasR, with an IC50 of 5.82 ± 0.17 μM, without any noted agonistic activity. Molecular modeling and molecular dynamics (MD) simulations indicated that NIC interacts with LasR, hindering its dimerization and destabilizing its structure. These findings were corroborated by sedimentation velocity experiments and thermal shift assays. NIC shows considerable promise as an antivirulence agent against P. aeruginosa by disrupting the LasR-mediated QS system. Through its interaction with LasR, NIC inhibits biofilm formation and diminishes the production of critical virulence factors, making P. aeruginosa less virulent and more vulnerable to conventional antibiotics and immune responses.
Insights
Niclosamide (NIC) effectively reduces virulence in Pseudomonas aeruginosa by disrupting its quorum sensing (QS) system. This antivirulence agent inhibits biofilm formation and key toxins, making the pathogen less harmful.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Discovery
Background:
- Pseudomonas aeruginosa is a significant pathogen causing difficult infections.
- Quorum sensing (QS) controls P. aeruginosa virulence factors.
- Targeting QS is a promising antivirulence strategy.
Purpose of the Study:
- To investigate niclosamide (NIC) as an antivirulence agent against P. aeruginosa.
- To evaluate NIC's impact on biofilm formation and pigment production.
- To determine NIC's molecular interaction with the LasR QS regulator.
Main Methods:
- In-silico, molecular, and in vitro analyses were performed.
- Sub-inhibitory NIC concentrations (64 μg/ml) were tested.
- Assays included biofilm inhibition, pigment production measurement, LasR interaction studies, molecular modeling, MD simulations, sedimentation velocity, and thermal shift assays.
Main Results:
- NIC significantly reduced biofilm formation (45.4%), pyocyanin (48.8%), and rhamnolipid (41.3%) production.
- NIC acted as a dose-dependent antagonist of LasR (IC50 = 5.82 μM) without agonistic effects.
- Molecular dynamics and experimental assays confirmed NIC's interaction with LasR, inhibiting dimerization and destabilizing its structure.
Conclusions:
- Niclosamide is a promising antivirulence agent against P. aeruginosa.
- NIC disrupts the LasR-mediated QS system, reducing virulence.
- NIC enhances susceptibility to antibiotics and immune responses by inhibiting key virulence factors.

